Transcript UK-RD-Opportunities-Short-v1

Collaboration in the Life Sciences
November 2011
A Guiding Principle
Collaboration -> Innovation -> Success
2
Especially in the Pharmaceutical Industry
 No single company has all the
necessary skills to develop a
pharmaceutical drug
 No single country has all the
necessary skills to develop a
pharmaceutical industry
Collaboration is vital, but…
…choose your partners with care.
3
What to look for in a good partner?
Scientific Excellence
Supportive
Environment
Commercial Awareness
Financial Competence
True for academic groups, companies and countries…
4
How does the UK rate?
5
The UK’s Position in the Global Market
Scientific Excellence
Supportive
Environment
Commercial Awareness
Financial Competence
True for academic groups, companies and countries…
6
A Key Feature…
“Almost half of more than 90,000 research articles
published by UK researchers in 2008
had a co-author from another country”.
…Creating a Success Story
 In Europe, the UK biotech sector is developing
– 40% of all biotechnology projects in pipeline
– 45% of new biotech drugs in late stage clinical trials
 The UK is a ‘super-cluster’ with organisations concentrated around
centres of excellence
– ‘Golden Triangle’ includes Cambridge, Oxford, London
 400+ biotechnology companies in the UK
– Industry employs nearly 20,000 people directly
– Generating revenues of $5 billion
Possesses all round expertise in drug discovery and development, in a
mature sector
8
The Golden Triangle
9
A Dense Environment of Biotechnology
 Key bio-cluster hubs of Cambridge,
London & Oxford
 Europe’s most dense region of life
science companies
 A highly-connected ecology of life
scientists, organisations and
companies.
 Majority of UK’s life science research
undertaken here
 Location of vast majority of major
Pharma’s EMEA operations
Major Pharma in Golden Triangle
Abbot Laboratories
Actelion
Almirral
Amgen
Astella Pharma
AstraZeneca
Baxter Healthcare
Boston Scientific
Bristol Myers Squibb
Cambridge Consultants
Chugai Pharma Europe
Daiichi Sankyo UK Ltd
Eisai Europe
Elan Pharma
Eli Lilly & Co
GE Healthcare
Genzyme
Gilead
GlaxoSmithKline
Huntleigh Healthcare
Ipsen
Johnson & Johnson
Lundbeck
Medtronic
Merch Sharp & Dohme
Mitsubishi Pharma Europe
Napp Pharmaceutical
Group
Novartis
Olympus
Ono Pharma
OSI
Pfizer
Philips
Roche
Sanofi Pasteur MSD
Schering Plough
Servier
Shire
Siemens Diagnostics
Smiths Medical
Stiefel
Takeda Global R&D Centre
Toyama Europe
United Therapeutics
UCB Celltech
Unilever
Vertex
Wyeth
Future developments planned in the
London - Cambridge Corridor
Cambridge
BioCluster
GSK + Govt backed £170M
science park on GSK campus for 2013
GSK Science
Park,
Stevenage
Oxford
Science Park
Ongoing Expansion of
Oxford Science Park
BioPark
Cluster,
Welwyn
Garden City
UKCMRI planned for 2016 £500M
World leading research institute
London Bio
and finance
cluster
Development of
Cambridge Biomedical
Campus
…and financial commitment
Chancellor George Osborne has said the Government will
protect the £4.6 billion science budget, which will see £220
million investment in the UK Centre for Medical Research and
Innovation at St Pancras, London.
NHS funding will increase from £104bn to £114bn over the
next four years, the chancellor of the exchequer has
confirmed.
13
How can you capitalise
on this Success Story?
14
How Technology Specialists Help
Overseas Companies
Overseas
In the UK
Overseas UKTI Groups
UKTI Sector & Business Groups
Science & Innovation Networks
Investment Team
Regional Organisations
Overseas
companies
Technology
Specialists
UK Technology
Capabilities
Provide
Activities
Detailed scientific information
Identify and assess R&D activities
Access to technology and
technology networks
Analyse business opportunities
Access to specific oganisions
Promote the UK
15
Conclusions
 Success in the BioPharma industry will require new
models of collaboration.
 The UK has a world-class life science industry, geared to
international collaboration
 The ‘Golden Triangle’ is home to most of the UK’s
BioPharma industry, and is continuing to thrive.
 UKTI can provide practical and dedicated support to
companies wishing to invest in the UK.
16
Thank You
Contact Details
Nigel Whittle PhD MBA
Technology Specialist | Life Sciences
UK Trade & Investment
1 Victoria Street
London SW1E 6SW
M: +44 (0) 7931 520 480
T: +44 (0) 1223 890 068
E: [email protected]
W: www.uktradeinvest.gov.uk
UK Trade & Investment is the Government organisation that helps UK based companies succeed in international markets.
It also assists overseas companies to bring high quality investment to the UK's vibrant economy.